Lilly Endowment INC reported 1 position with a total reported value of $108.4B as of 2026-06-30, in its 13F for Q2 2026, filed 2026-07-23. Top holdings by reported value: LLY Eli Lilly and Company (100.0%). Against 2026-03-31 it opened 0 new positions and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Lilly Endowment INC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| LLY Eli Lilly and Company | 90,376,978 | $108.4B | 100.0% |
No new positions.
No positions were sold out.
No position was increased.
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| LLY Eli Lilly and Company | 91,896,978 | 90,376,978 | -1.7% | $108.4B |
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms
No password to create and no card required. We store your email address and nothing else.